Lamina Surgical, Inc.
About Lamina Surgical, Inc.
Lamina Surgical, Inc. is developing the CoronaBlade technology, a next-generation electrosurgical platform for precision tissue dissection, integrated illumination, and reduced thermal spread in operating rooms. The company combines expertise from Medtronic, Johnson & Johnson, ConMed, Invuity, and ArthroCare to commercialize open-surgery solutions. Its leadership has previously developed FDA-cleared surgical platforms and built companies through strategic acquisitions.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $490,000 in private placement funding.
- Developing CoronaBlade electrosurgical platform with proprietary blade insulation.
- Team includes veterans from Medtronic, Johnson & Johnson, and ArthroCare.
- Located in Oakland, CA and focused on improving open surgery outcomes.
Ask StreetZero about Lamina Surgical, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account